Halozyme Therapeutics shares owned by Knights of Columbus Asset Advisors
Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Knights of Columbus Asset Advisors
from 13F filings
Historical chart of Knights of Columbus Asset Advisors investment in Halozyme Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Halozyme Therapeutics held by Knights of Columbus Asset Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Halozyme Therapeutics by Knights of Columbus Asset Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $6.9M | 186k | 36.96 |
| 2023-09-30 | $3.6M | 93k | 38.20 |
| 2023-06-30 | $2.9M | 80k | 36.07 |
| 2023-03-31 | $3.0M | 80k | 38.19 |
| 2022-12-31 | $4.3M | 75k | 56.90 |
| 2022-09-30 | $3.6M | 91k | 39.54 |
| 2022-06-30 | $3.7M | 84k | 44.00 |
| 2022-03-31 | $2.0M | 51k | 39.88 |
| 2021-12-31 | $2.0M | 51k | 40.21 |
| 2021-09-30 | $2.0M | 50k | 40.68 |
More positions owned by Knights of Columbus Asset Advisors
View all positions for Knights of Columbus Asset Advisors